BCG
NVO

Breakwater Capital Group’s Novo Nordisk NVO Stock Holding History

Breakwater Capital Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,555
Closed -$220K – 331
2024
Q4 		$220K Sell
2,555
-300
-11% -$32.4K 0.04% 274
2024
Q3 		$340K Buy
2,855
+242
+9% +$32.3K 0.07% 221
2024
Q2 		$373K Hold
2,613
– – 0.08% 195
2024
Q1 		$336K Buy
2,613
+76
+3% +$9.05K 0.08% 192
2023
Q4 		$268K Buy
2,537
+382
+18% +$37.8K 0.08% 202
2023
Q3 		$211K Buy
+2,155
New +$190K 0.07% 203

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Breakwater Capital Group's NVO Position: Q1 2025 in Review

Breakwater Capital Group sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,555 shares — an estimated $220K sold.

Breakwater Capital Group first reported a position in NVO in Q3 2023 and held it in 6 quarters. The position peaked at $373K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Breakwater Capital Group reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Breakwater Capital Group sold 2,555 Novo Nordisk shares in Q1 2025, an estimated $220K.
  • Breakwater Capital Group first reported a position in Novo Nordisk in Q3 2023 and held it in 6 quarters.
  • Breakwater Capital Group's Novo Nordisk position peaked at $373K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Breakwater Capital Group's 13F filing for Q1 2025, filed 10 Apr 2025.